Related Experiment Video
Updated: Jun 18, 2026

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
Phenobarbital (PB)-induced changes in blood coagulationrelated parameters in pregnant rats, lactating rats and pups
Masahiro Mochizuki1, Satomi Shimizu, Yuri Kidokoro
1Bozo Research Center Inc. Shizuoka, Japan. mochizuki@bozo.co.jp
Insights
Phenobarbital (PB) administration prolonged blood clotting times in lactating rats and their pups. Vitamin K2 (VK2) improved clotting in pups but not dams, indicating differential effects.
Area of Science:
- Pharmacology
- Toxicology
- Biochemistry
Background:
- Phenobarbital (PB) is known to affect liver enzymes and drug metabolism.
- The impact of PB on blood coagulation, particularly during pregnancy and lactation, requires further investigation.
- Understanding these effects is crucial for assessing risks in vulnerable populations.
Purpose of the Study:
- To investigate the effects of repeated phenobarbital (PB) administration on blood coagulation parameters in non-pregnant, pregnant, and lactating rats.
- To evaluate the impact of PB exposure on coagulation in pups born to treated dams.
- To assess the efficacy of vitamin K2 (VK2) in mitigating PB-induced coagulation changes.
Main Methods:
- Rats (non-pregnant, pregnant, lactating) received daily oral doses of PB (80 mg/kg) for 7 days.
- Blood samples were collected for coagulation tests (PT, APTT) and anti-thrombin III (ATIII) concentration.
- Coagulation parameters were also assessed in pups born to PB-treated lactating dams.
- Co-administration of PB and VK2 was used to evaluate VK2's protective effects.
Main Results:
- PB increased liver weight and hepatic cytochrome P450 content in treated rats.
- Lactating rats showed prolonged activated partial thromboplastin time (APTT) and increased anti-thrombin III (ATIII) concentration.
- Pups exhibited prolonged prothrombin time (PT) and APTT, with decreased factors VII and IX activities.
- Vitamin K2 (VK2) improved PB-induced coagulation prolongation in pups but not in dams.
Conclusions:
- Repeated PB administration significantly alters blood coagulation in lactating rats and their offspring.
- PB exposure during lactation poses a risk for coagulation disturbances in both dams and pups.
- Vitamin K2 (VK2) shows potential therapeutic benefit for PB-induced coagulopathy in pups, but not in dams.
Abstract:
Effects of repeated administration of phenobarbital (PB) on blood coagulation-related parameters were examined in non-pregnant, pregnant and lactating rats, and also in pups born to PB-treated lactating dams. PB was orally administered at a dose level of 80 mg/kg/day to pregnant (from gestation day (GD) 13), postpartum (from postpartum day (PPD) 7) and non-pregnant rats (from 13 weeks of age) for 7 days. Blood was collected on GD20 or PPD14 to perform blood coagulation examination. Concurrently, the blood coagulation parameters were examined in the pups. Increases in liver weight and/or hepatic cytochrome P450 content were observed in the PB-treated non-pregnant, pregnant and lactating rats. Activated partial thromboplastin time (APTT) was prolonged and anti-thrombin III (ATIII) concentration was increased in the lactating rats, while there were no changes in prothrombin time (PT) or APTT in the non-pregnant and pregnant rats. Moreover, prolongation of PT and APTT and decreases in factors VII and IX activities were observed in their pups. Thus, prolongation of blood coagulation time was confirmed in both dams and their pups following PB-administration to lactating dams. Effects of vitamin K(2) (VK(2)) on PB-induced changes in blood coagulation-related parameters of both dams and their pups were examined by co-administration with PB and VK(2) to lactating dams. PT and APTT were comparable to the control and PB-induced prolongation of blood coagulation time was improved in the pups while APTT was prolonged in dams, suggesting that VK(2) was beneficial to pups but not to dams.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Sedatives and Hypnotics Drugs: Barbiturates
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Teratogenicity